NeuroVision Imaging Acquires Durin Life Sciences
May 12, 2026
NeuroVision Imaging Inc. acquired Durin Life Sciences Inc. to create an integrated platform for earlier detection and longitudinal management of neurodegenerative diseases. The deal combines Durin’s blood-based biomarker diagnostics (Duritect) with NeuroVision’s retinal imaging, telehealth infrastructure, and BrainHealth.net patient engagement ecosystem.
- Buyers
- NeuroVision Imaging Inc.
- Targets
- Durin Life Sciences Inc.
- Sellers
- Ric Edelman (majority owner of Durin Life Sciences)
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.